Jennifer Chu, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 225 Wilmington W Chester Pike Ste 200, Chadds Ford, PA 19317 Phone: 410-740-2370 |
News Archive
Opexa Therapeutics, Inc., a company developing a novel T-cell therapy for multiple sclerosis, announced today that the company will participate in a panel discussion on Personalized Medicine for the Treatment of Multiple Sclerosis on April 7, 2010.
David Metzger, director of the HIV/AIDS Prevention Research Division at the University of Pennsylvania, and colleagues plan to launch a trial in China among injection drug users to determine if a drug that reduces the craving for heroin also can reduce the spread of HIV through the sharing of contaminated needles, the Philadelphia Inquirer reports.
Biogen Idec Inc. today reported third quarter 2013 total revenues of $1.8 billion, an increase of 32% over the third quarter of 2012. Non-GAAP diluted EPS for the third quarter of 2013 were $2.35, an increase of 23% over the third quarter of 2012.
A study by researchers at Royal Holloway, University of London, University College London and Oxford University, has found that a genetic variant which reduces the chance of contracting diseases such as tuberculosis and leprosy is more prevalent in populations with long histories of urban living.
› Verified 7 days ago